logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11352405 B1

PDFFull Text
Date of Patent:
Jun. 07, 2022

Filed:

Aug. 08, 2018

Glp-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis

Applicant:

Sanofi, Paris, FR;

Inventors:

Aimo Kannt, Frankfurt am Main, DE;

Maximilian Bielohuby, Frankfurt am Main, DE;

Ralf Elvert, Frankfurt am Main, DE;

Michael Wagner, Frankfurt am Main, DE;

Martin Bossart, Frankfurt am Main, DE;

Torsten Haack, Frankfurt am Main, DE;

Stephanie Keil, Frankfurt am Main, DE;

Werner Seiz, Frankfurt am Main, DE;

Assignee:

SANOFI, Paris, FR;

Attorneys:

Lathrop GPM LLP

James H. Velema, Esq.

Primary Examiner:

Julie Ha

Assistant Examiner:

Kristina M Hellman

Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61K 38/26 (2006.01); A61K 45/06 (2006.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); C07K 14/605 (2006.01);
U.S. Cl.
CPC ...
C07K 14/605 (2013.01); A61P 1/16 (2018.01); A61P 3/10 (2018.01); A61K 38/00 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to the medical use of specific GLP-1/glucagon receptor agonists in the prevention and/or treatment of metabolic liver disease, particularly non-alcoholic fatty liver disease (NAFLD), more particularly non-alcoholic fatty liver (NAFL), non-alcoholic steatohepatitis (NASH) and/or NAFLD-associated liver fibrosis.

Find Patent Forward Citations

Quick Actions:

Kannt, Aimo. (2022). Glp-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis (U.S. Patent No. 11352405). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11352405

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…